Urinary epidermal growth factor predicts renal prognosis in antineutrophil cytoplasmic antibody-associated vasculitis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2018-05-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/annrheumdis-2017-212578PMID 29724728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.

  2016cited by this paper
• End‐stage renal disease in ANCA‐associated vasculitis

  2016cited by this paper
• Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary Glomerulonephritis

  2016cited by this paper
• Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker

  2015cited by this paper
• Predictors of Treatment Resistance and Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Study of 439 Cases in a Single Chinese Center

  2014cited by this paper
• Predicting hemoglobin levels in whole blood donors using transition models and mixed effects models

  2013cited by this paper
• 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

  2013cited by this paper
• The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution.

  2013cited by this paper
• Simultaneous monitoring of multiple urinary cytokines may predict renal and patient outcome in ischemic AKI

  2010cited by this paper
• Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Older Patients

  2008cited by this paper
• The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy.

  2008cited by this paper
• Opposing roles of EGF in IFN-alpha-induced epithelial barrier destabilization and tissue repair.

  2007cited by this paper
• Opposing roles of EGF in IFN-α-induced epithelial barrier destabilization and tissue repair

  2007cited by this paper
• EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

  2006cited by this paper
• Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy

  2006cited by this paper
• Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.

  2006cited by this paper
• Epithelial cell migration in response to epidermal growth factor.

  2006cited by this paper
• Gene expression profiling analysis in nephrology: towards molecular definition of renal disease

  2006cited by this paper
• Predictors of Relapse and Treatment Resistance in Antineutrophil Cytoplasmic AntibodyAssociated Small-Vessel Vasculitis

  2005cited by this paper
• Rapidly progressive crescentic glomerulonephritis.

  2003cited by this paper
• Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.

  2002cited by this paper
• MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy.

  2000cited by this paper
• Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis.

  1999cited by this paper
• Urinary Epidermal Growth Factor Excretion in Children with Chronic Renal Failure

  1999cited by this paper
• The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement.

  1996cited by this paper
• Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

  1996cited by this paper
• Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

  1996cited by this paper
• Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study.

  1996cited by this paper
• Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

  1994cited by this paper
• Membrane-anchored growth factors.

  1993cited by this paper
• Mechanism of sodium transport inhibition by epidermal growth factor in cortical collecting ducts.

  1991cited by this paper
• Reduced Urinary Excretion of Epidermal Growth Factor in Incipient and Overt Diabetic Nephropathy

  1989cited by this paper
• Epidermal growth factor and the kidney.

  1989cited by this paper
• Effect of epidermal growth factor on sodium transport in the cortical collecting tubule.

  1989cited by this paper
• Receptors for epidermal growth factor and other polypeptide mitogens.

  1987cited by this paper
• Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin

  1978cited by this paper
• Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

  1962cited by this paper

• The Assessment of Disease Activity and Renal Prognosis in AAV – The Contribution of Urinary Biomarkers and Renal Biopsy

  2026cites this paper
• Biomarkers in ANCA associated vasculitis: clinical utility, pitfalls and their role in the outcomes assessment

  2025cites this paper
• Conductometric Biosensor for Quick Detection of Urinary Biomarkers in Chronic Kidney Disease Management.

  2025cites this paper
• Non-invasive biomarkers of disease activity and organ damage in ANCA-associated vasculitis: a systematic review

  2024cites this paper
• Urinary EGF Reflects Distal Tubular Mass and Is Associated with Hypertension, Serum Magnesium, and Kidney Outcomes

  2024cites this paper
• Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study

  2024cites this paper
• Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China: Epidemiology, Management, Prognosis, and Outlook

  2024cites this paper
• Urinary epidermal growth factor in kidney disease: A systematic review

  2023cites this paper
• Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA – associated vasculitis

  2023cites this paper
• Urinary epidermal growth factor predicts complete remission of proteinuria in Chinese children with IgA nephropathy

  2023cites this paper
• Intraindividual variations of urinary biomarkers in hospitalized children with glomerular diseases: a prospective observational study

  2023cites this paper
• The determination of epidermal growth factor in Edible bird's nest by enzyme-linked immunosorbent assay

  2023cites this paper
• The Michigan O'Brien Kidney Research Center - transforming translational kidney research through systems biology.

  2022cites this paper
• Urinary Matrix Metalloproteinase 7 Activated by Oxidative Stress Predicts Kidney Prognosis in Myeloperoxidase–Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

  2022cites this paper
• Proteome-Wide Analysis Using SOMAscan Identifies and Validates Epidermal Growth Factor as a Disease Marker of Collagenous Gastritis

  2022cites this paper
• Urinary Epidermal Growth Factor: A Promising “Next Generation” Biomarker in Kidney Disease

  2022cites this paper
• Old known and possible new biomarkers of ANCA-associated vasculitis.

  2022cites this paper
• Advancing science and education through a novel collaboration platform between the University of Michigan and Peking University Health Science Center

  2021cites this paper
• The Lupus Nephritis Management Renaissance.

  2021cites this paper
• Renal-limited ANCA-associated vasculitis during erlotinib treatment for lung carcinoma

  2021cites this paper
• Systematic Scoring of Tubular Injury Patterns Reveals Interplay between Distinct Tubular and Glomerular Lesions in ANCA-Associated Glomerulonephritis

  2021cites this paper
• Perspectives in systems nephrology

  2021cites this paper
• Urinary EGF and MCP-1 and risk of CKD after cardiac surgery

  2021cites this paper
• Association Between Urinary Epidermal Growth Factor and Renal Prognosis in Lupus Nephritis

  2020cites this paper
• Mass spectrometry-based proteomic exploration of the small urinary extracellular vesicles in ANCA-associated vasculitis in comparison with total urine.

  2020cites this paper
• Integrated multi-omics approaches to improve classification of chronic kidney disease

  2020cites this paper
• Response to: ‘Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated’ by Moiseev et al

  2018cites this paper
• Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated

  2018cites this paper